Literature DB >> 8541245

Cognitive impairment as a target for pharmacological treatment in schizophrenia.

M Davidson1, R S Keefe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541245     DOI: 10.1016/0920-9964(95)00037-m

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  14 in total

1.  Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.

Authors:  Anita L Pinner; Janusz Tucholski; Vahram Haroutunian; Robert E McCullumsmith; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2016-02-11       Impact factor: 4.939

Review 2.  Implementation considerations for multisite clinical trials with cognitive neuroscience tasks.

Authors:  Richard S E Keefe; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

Review 3.  Cognition in schizophrenia.

Authors:  P D Harvey; C R Bowie; J I Friedman
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

4.  Schizophrenia patients with cognitive deficits: factors associated with costs.

Authors:  Anita Patel; Brian Everitt; Martin Knapp; Clare Reeder; Deidre Grant; Christine Ecker; Til Wykes
Journal:  Schizophr Bull       Date:  2006-08-02       Impact factor: 9.306

5.  Should cognitive impairment be included in the diagnostic criteria for schizophrenia?

Authors:  Richard S E Keefe
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

Review 6.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Authors:  Stacy A Castner; Patricia S Goldman-Rakic; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

7.  Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications.

Authors:  Richard S E Keefe; Margaret P Poe; Joseph P McEvoy; Adam Vaughan
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

Review 8.  How should DSM-V criteria for schizophrenia include cognitive impairment?

Authors:  Richard S E Keefe; Wayne S Fenton
Journal:  Schizophr Bull       Date:  2007-06-13       Impact factor: 9.306

Review 9.  A review of the effects of modafinil on cognition in schizophrenia.

Authors:  Sharon Morein-Zamir; Danielle C Turner; Barbara J Sahakian
Journal:  Schizophr Bull       Date:  2007-07-18       Impact factor: 9.306

10.  The influence of social interaction on cognitive training for schizophrenia.

Authors:  Jennifer Louise Cook; Jennifer Black
Journal:  Front Neurosci       Date:  2012-09-28       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.